2.2.0.25falsefalse0203 - Disclosure - Acquisitionstruefalsefalse1falsefalseUSDfalsefalse1/1/2010 - 12/31/2010
USD ($)
USD ($) / shares
$Jan-01-2010_Dec-31-2010http://www.sec.gov/CIK0001027884duration2010-01-01T00:00:002010-12-31T00:00:00USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDEPSDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0cbi_AcquisitionsAbstractcbifalsenadurationAcquisitions Abstract.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringAcquisitions Abstract.falsefalse3false0us-gaap_BusinessCombinationDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<!-- Begin Block Tagged Note 3 - us-gaap:BusinessCombinationDisclosureTextBlock-->
<div style="margin-left: 0%">
<div style="margin-top: 8pt; font-size: 1pt"> 
</div>
<table width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Arial, Helvetica; color: #000000; background: transparent; text-align: left">
<tr>
<td width="3%"></td>
<td width="97%"></td>
</tr>
<tr valign="top">
<td>
<b><font style="font-family: 'Times New Roman', Times">3.  </font></b>
</td>
<td>
<b><font style="font-family: 'Times New Roman', Times">ACQUISITIONS</font></b>
</td>
</tr>
</table>
<div style="margin-top: 4pt; font-size: 1pt"> 
</div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent">
Through December 31, 2010, we held a 50% equity investment
in Catalytic Distillation Technologies (“CD Tech”),
which provides license/basic engineering and catalyst supply for
catalytic distillation applications, including gasoline
desulphurization and alkylation processes. This investment was
accounted for by the equity method and was reflected in the
operating results of Lummus Technology. On December 31,
2010, we acquired Chemical Research and Licensing
(“CR&L”) from CRI/Criterion, a subsidiary of
Royal Dutch Shell plc., for approximately $38,400, net of cash
acquired. The acquisition of CR&L included a research and
development and catalyst manufacturing facility, and enabled us
to assume the remaining 50% equity interest in CD Tech. The
future results of operations of CD Tech will be consolidated and
will continue to reside within Lummus Technology.
</div>
<div style="margin-top: 4pt; font-size: 1pt"> 
</div>
<div align="left" style="margin-left: 0%; margin-right: 0%; text-indent: 4%; font-size: 10pt; font-family: 'Times New Roman', Times; color: #000000; background: transparent">
The preliminary aggregate purchase price noted above was
allocated to the major categories of assets and liabilities
acquired based upon their estimated fair values, none of which
were significant to our Consolidated Balance Sheet at
December 31, 2010. The balances included in our 2010
Consolidated Balance Sheet were based on preliminary information
and are subject to change when additional information concerning
final asset and liability valuations is obtained.
</div>
</div>
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" -->
<!-- Begin Block Tagged NotefalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDescription of a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. This element may be used as a single block of text to encapsulate the entire disclosure (including data and tables) regarding business combinations, including leverage buyout transactions (as applicable).Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51, 52
Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 88-16
Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 67-73
Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph F4
-Subparagraph e
-Appendix F
falsefalse12AcquisitionsUnKnownUnKnownUnKnownUnKnownfalsetrue